We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.11%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$303M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.2M
3
IYR icon
iShares US Real Estate ETF
IYR
+$17.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.7M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.4M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$26.8M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$24.6M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$24.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$24M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.2M

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DDS icon
901
Dillards
DDS
$9.7B
$81K 0.01%
1,278
+1,178
+1,178% +$73.6K
ZBRA icon
902
Zebra Technologies
ZBRA
$17.7B
$81K 0.01%
1,166
-82
-7% -$5.04K
CHK
903
DELISTED
Chesapeake Energy Corporation
CHK
$81K 0.01%
+65
New +$75K
CASC
904
DELISTED
Cascadian Therapeutics, Inc.
CASC
$81K 0.01%
8,263
+341
+4% +$2.42K
FBIN icon
905
Fortune Brands Innovations
FBIN
$6.22B
$80K 0.01%
1,613
-523
-24% -$27.4K
FCN icon
906
FTI Consulting
FCN
$4.29B
$80K 0.01%
1,799
-771
-30% -$33.3K
PARAA
907
DELISTED
Paramount Global Class A
PARAA
$80K 0.01%
1,448
+733
+103% +$40.3K
SPLV icon
908
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$80K 0.01%
+1,924
New +$81.4K
VMW
909
DELISTED
VMware, Inc
VMW
$80K 0.01%
1,088
-30
-3% -$2.11K
MENT
910
DELISTED
Mentor Graphics Corp
MENT
$80K 0.01%
3,035
-2,915
-49% -$66.2K
AEE icon
911
Ameren
AEE
$30B
$79K 0.01%
1,618
-5,847
-78% -$298K
BDN
912
Brandywine Realty Trust
BDN
$546M
$79K 0.01%
5,060
+4,638
+1,099% +$75.6K
EGHT icon
913
8x8 Inc
EGHT
$326M
$79K 0.01%
5,092
+2,597
+104% +$36.9K
HEI icon
914
HEICO Corp
HEI
$51.5B
$79K 0.01%
+2,795
New +$79K
IVLU icon
915
iShares MSCI Intl Value Factor ETF
IVLU
$4.5B
$79K 0.01%
+3,648
New +$76.9K
MEDP icon
916
Medpace
MEDP
$16.3B
$79K 0.01%
+2,637
New +$77K
PCRX icon
917
Pacira BioSciences
PCRX
$987M
$79K 0.01%
2,313
-3,623
-61% -$142K
UTHR icon
918
United Therapeutics
UTHR
$22.1B
$79K 0.01%
+669
New +$80.4K
BBU
919
DELISTED
Brookfield Business Partners
BBU
$78K 0.01%
4,605
-1,300
-22% -$18.2K
GD icon
920
General Dynamics
GD
$104B
$78K 0.01%
500
-2,166
-81% -$323K
HSBC icon
921
HSBC
HSBC
$351B
$78K 0.01%
2,308
+1,904
+471% +$59.8K
PLD icon
922
Prologis
PLD
$131B
$78K 0.01%
1,456
-1,581
-52% -$83.4K
SITC icon
923
SITE Centers
SITC
$172M
$78K 0.01%
3,489
-2,887
-45% -$69.6K
TBRG
924
DELISTED
TruBridge
TBRG
$78K 0.01%
2,976
+2,014
+209% +$63.2K
MDRX
925
DELISTED
Veradigm Inc. Common Stock
MDRX
$78K 0.01%
5,912
+4,508
+321% +$60.3K
35 36
37
38 39

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.